[go: up one dir, main page]

ES2170177T3 - Benzotienilpiperazinas sustituidas, su uso como medicamentos y procedimientos para su preparacion. - Google Patents

Benzotienilpiperazinas sustituidas, su uso como medicamentos y procedimientos para su preparacion.

Info

Publication number
ES2170177T3
ES2170177T3 ES96103772T ES96103772T ES2170177T3 ES 2170177 T3 ES2170177 T3 ES 2170177T3 ES 96103772 T ES96103772 T ES 96103772T ES 96103772 T ES96103772 T ES 96103772T ES 2170177 T3 ES2170177 T3 ES 2170177T3
Authority
ES
Spain
Prior art keywords
sub
sup
carbon
hydrogen
rent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96103772T
Other languages
English (en)
Inventor
Nicholas J Hirb
John Jurcak
Abdul E Mutlib
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Aventis Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc filed Critical Aventis Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2170177T3 publication Critical patent/ES2170177T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/66Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

ESTA INVENCION SE REFIERE A COMPUESTOS DE FORMULA I EN DONDE X ES HIDROGENO, HALOGENO, HIDROXILO, (C{SUB,1}-C{SUB,6}) ALCOXI, AMINO O TRIFLUOROMETIL; E Y ES -CN O -NR{SUP,1}R{SUP,2}: DONDE L ES UN ENTERO DE VALOR 1 O 2; M ES UN ENTERO DE VALOR 0, 1 O 2; N ES UN ENTERO DE VALOR 2, 3 O 4, EXCEPTO CUANDO Y ES CN, EN CUYO CASO N PUEDE TAMBIEN SER 1; R{SUP,1} ES HIDROGENO, (C{SUB,1}-C{SUB,6}) ALQUIL O (C{SUB,1}C{SUB,6}) ALQUILCARBONIL; R{SUP,2} ES HIDROGENO, (C{SUB,1}-C{SUB,10}) ALQUILCARBONIL, (C{SUB,3}-C{SUB,12}) CICLOALQUILCARBONIL, HIDROXI-(C{SUB,1}C{SUB,6}) ALQUILCARBONIL, FENILCARBONIL, TIENILCARBONIL O BENZOTIENILCARBONIL; O R{SUP,1} Y R{SUP,2} JUNTO CON UN ATOMO DE NITROGENO AL CUAL ESTAN ADHERIDOS EN FORMA DE ANILLO DONDE A ES C= O O CH{SUB,2}; Y B ES C= O, CHOH, CH{SUB,2} O CH{SUB,2}CH{SUB,2}; Y Z ES HIDROGENO, HALOGENO, HIDROXI, (C{SUB,1}-C{SUB,6}) ALCOXI, AMINO O TRIFLUOR; Y SUS SALES ACIDAS DE ADICION FARMACEUTICAMENTE ACEPTABLES, COMPOSICIONES FARMACEUTICAS DE ELLAS Y SU USO PARA EL TRATAMIENTO DE LA PSICOSIS.
ES96103772T 1995-03-17 1996-03-11 Benzotienilpiperazinas sustituidas, su uso como medicamentos y procedimientos para su preparacion. Expired - Lifetime ES2170177T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US41381895A 1995-03-17 1995-03-17

Publications (1)

Publication Number Publication Date
ES2170177T3 true ES2170177T3 (es) 2002-08-01

Family

ID=23638775

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96103772T Expired - Lifetime ES2170177T3 (es) 1995-03-17 1996-03-11 Benzotienilpiperazinas sustituidas, su uso como medicamentos y procedimientos para su preparacion.

Country Status (23)

Country Link
US (1) US5801176A (es)
EP (1) EP0732332B1 (es)
JP (1) JPH093060A (es)
KR (1) KR100402510B1 (es)
CN (1) CN1082959C (es)
AT (1) ATE211137T1 (es)
AU (1) AU700077B2 (es)
CA (1) CA2171695A1 (es)
CZ (1) CZ80496A3 (es)
DE (1) DE69618050T2 (es)
DK (1) DK0732332T3 (es)
ES (1) ES2170177T3 (es)
HU (1) HUP9600665A3 (es)
IL (1) IL117519A (es)
NO (1) NO315652B1 (es)
NZ (1) NZ286186A (es)
PL (1) PL182310B1 (es)
PT (1) PT732332E (es)
RO (1) RO117453B1 (es)
RU (1) RU2157371C2 (es)
SG (1) SG54269A1 (es)
TW (1) TW328957B (es)
ZA (1) ZA962075B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5703083A (en) * 1996-04-15 1997-12-30 Neurogen Corporation N-aminoalkyl-1-biphenylenyl-2-carboxamides; new dopamine receptor subtype specific ligands
US6642228B1 (en) 1999-06-24 2003-11-04 Toray Industries, Inc. α1b-adrenergic receptor antagonists
GB0117531D0 (en) * 2001-02-16 2001-09-12 Aventis Pharm Prod Inc Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
DE60216753T2 (de) * 2001-02-16 2008-01-03 Aventis Pharmaceuticals Inc. Heterocyclische harnstoffderivate und deren verwendung als dopamine d3 receptor liganden
IL157412A0 (en) * 2001-02-16 2004-03-28 Aventis Pharmaceuticals Inc Av Novel heterocyclic amide derivatives and their use as dopamine d3 receptor ligands
WO2002078669A1 (fr) * 2001-03-30 2002-10-10 Takeda Chemical Industries, Ltd. Solutions medicinales
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
TWI329641B (en) 2005-08-31 2010-09-01 Otsuka Pharma Co Ltd (benzo[b]thiophen-4-yl)piperazine compounds, pharmaceutical compositions comprising the same, uses of the same and processes for preparing the same
CN105985314A (zh) * 2015-02-05 2016-10-05 苏州旺山旺水生物医药有限公司 布瑞哌唑类似物的制备方法
US20220213079A1 (en) * 2019-12-24 2022-07-07 Sumitomo Dainippon Pharma Co., Ltd. Aliphatic acid amide derivative

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK169601B1 (da) * 1983-10-17 1994-12-19 Duphar Int Res Piperazinderivater og farmaceutisk præparat indeholdende et sådant derivat, samt piperazinderivater med mellemproduktanvendelse
EP0316723B1 (en) * 1987-11-20 1992-09-30 Hoechst-Roussel Pharmaceuticals Incorporated 3-[4(1-Substituted-4-piperazinyl)butyl]-4-thiazolidinones a process for their preparation and their use as medicaments
US4780466A (en) * 1988-03-17 1988-10-25 Hoechst-Roussel Pharmaceuticals, Inc. Arylpiperazinylalkoxy derivatives of cyclic imides
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
US4968792A (en) * 1989-09-25 1990-11-06 American Home Products Corporation Psychotropic benzisothiazole derivatives
US5143923B1 (en) * 1991-04-29 1993-11-02 Hoechst-Roussel Pharmaceuticals Incorporated Benzoisothiazole-and benzisoxazole-3-carboxamides
GB9202915D0 (en) * 1992-02-12 1992-03-25 Wellcome Found Chemical compounds
US5240927A (en) * 1992-05-19 1993-08-31 Hoechst-Roussel Pharmaceuticals Incorporated Benzo[β]thiophen-3-yl piperazines as antipsychotic agents
GB9302622D0 (en) * 1993-02-10 1993-03-24 Wellcome Found Heteroaromatic compounds
US5395835A (en) * 1994-03-24 1995-03-07 Warner-Lambert Company Naphthalamides as central nervous system agents
GB9410031D0 (en) * 1994-05-19 1994-07-06 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
DK0732332T3 (da) 2002-04-15
IL117519A0 (en) 1996-07-23
NO961077D0 (no) 1996-03-15
NZ286186A (en) 1997-07-27
PL313251A1 (en) 1996-09-30
PL182310B1 (pl) 2001-12-31
AU4811396A (en) 1996-09-26
HUP9600665A2 (en) 1997-10-28
TW328957B (en) 1998-04-01
CA2171695A1 (en) 1996-09-18
KR960034201A (ko) 1996-10-22
EP0732332A1 (en) 1996-09-18
RO117453B1 (ro) 2002-03-29
RU2157371C2 (ru) 2000-10-10
PT732332E (pt) 2002-06-28
IL117519A (en) 2000-08-31
AU700077B2 (en) 1998-12-17
CN1139108A (zh) 1997-01-01
DE69618050D1 (de) 2002-01-31
DE69618050T2 (de) 2002-07-11
SG54269A1 (en) 1998-11-16
JPH093060A (ja) 1997-01-07
ZA962075B (en) 1997-12-31
HUP9600665A3 (en) 1998-08-28
NO961077L (no) 1996-09-18
KR100402510B1 (ko) 2004-03-18
EP0732332B1 (en) 2001-12-19
CZ80496A3 (en) 1996-10-16
CN1082959C (zh) 2002-04-17
NO315652B1 (no) 2003-10-06
US5801176A (en) 1998-09-01
ATE211137T1 (de) 2002-01-15
HU9600665D0 (en) 1996-05-28

Similar Documents

Publication Publication Date Title
GT200000037A (es) Procedimientos e intermedios para preparar compuestos anticancerosos.
PA8472301A1 (es) Derivados de isotiazol utiles como agentes anticancerosos
UA66825C2 (uk) Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності
CY1106239T1 (el) ΦΑΡΜΑΚΕΥΤΙΚΕΣ ΔΙΑΜΟΡΦΩΣΕΙΣ ΕΛΕΓΧΟΜΕΝΗΣ ΑΠΕΛΕΥΘΕΡΩΣΗΣ ΠΟΥ ΠEPΙΕΧΟΥΝ ΑΝΑΣΤΟΛΕΑ cGMP PDE-5
AR022860A1 (es) Derivados de camptotecina que poseen actividad antitumoral
AR023423A1 (es) Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos
BG103417A (en) Condensed pyrimidine bicyclic derivatives
AR028810A1 (es) Derivados de arilpiperazinil-ciclohexil indol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos para el tratamiento de la depresion
ES2153098T3 (es) Derivados de quinazolina.
AR012588A1 (es) UN INHIBIDOR DE SERINA PROTEASA, UNA COMPOSICIoN FARMACEUTICA QUE LO COMPRENDE Y UN PROCEDIMIENTO PARA PREPARAR UNA COMPOSICIoN FARMACEUTICA
ATE290015T1 (de) Cyclosporinderivate, deren herstellung und pharmazeutische zubereitungen
BG106586A (en) Pyrazolopyramidines as therapeutic agents
PA8593001A1 (es) Derivados de pirimidina para el tratamiento del crecimiento celular anormal
ATE249214T1 (de) Pentafluorobenzensulfonamide und analoge
SE9904508D0 (sv) New compounds
BR0313942A (pt) Derivados de benzimidazol úteis como agentes antiproliferativos
ATE232520T1 (de) Imidazolidin-4-on derivate verwendbar als antikrebsmittel
ES2170177T3 (es) Benzotienilpiperazinas sustituidas, su uso como medicamentos y procedimientos para su preparacion.
DE68901153D1 (de) Derivate von purin, verfahren zu ihrer herstellung und pharmazeutische zubereitung.
IS4923A (is) Meðferðaráform við inngjöf á H+,K+-ATPasa-blokkara
SV2004001363A (es) Derivados del 3-azabiciclo[3.1.0]hexano, ref. pc23113
BR9608488A (pt) Uso de derivados da vitamina d4 no tratamento de câncer
MXPA04001250A (es) Derivados de arilsulfonilo con afinidad receptora de 5-hidroxitriptamina6 (5-ht6).
BR0107493A (pt) Substâncias para uso no tratamento de psorìase
BG106008A (en) Novel lhrh antagonists with improved solubility characteristics

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 732332

Country of ref document: ES